id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-E-1234-0006,FDA,FDA-2012-E-1234,"Determination of Regulatory Review Period for Purposes of Patent
Extension; STENDRA",Notice,General Notice,2014-06-10T04:00:00Z,2014,6,2014-06-10T04:00:00Z,2014-08-12T03:59:59Z,2014-06-10T16:04:46Z,2014-13444,0,0,090000648173521c
FDA-2012-E-1234-0005,FDA,FDA-2012-E-1234,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2014-05-12T04:00:00Z,2014,5,2014-05-12T04:00:00Z,,2014-05-12T16:40:07Z,,0,0,09000064816f1540
FDA-2012-E-1234-0004,FDA,FDA-2012-E-1234,Letter from U.S. Patent and Trademark Office  to FDA CDER,Other,Letter(s),2014-03-28T04:00:00Z,2014,3,2014-03-28T04:00:00Z,,2014-03-28T20:00:27Z,,0,0,090000648168cf7a